L-Day: Syngene shares soar superb

Syngene is said to be the only listed CRO in India


Dr Kiran Mazumdar-Shaw, CMD, Biocon

Shares of Syngene International, a CRO and a subsidiary of biopharmaceutical behemoth Biocon, were listed at Rs 295 today, against its issue price of Rs 250 per share, on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

Its shares opened at 18% higher, and hit a high of Rs 315 on BSE, up by 26%.

In July 2015, through its Initial Public Offering (IPO), Syngene raised INR 550 crore, and was subscribed more than 32-times.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email